WST

WST

USD

West Pharmaceutical Services Inc. Common Stock

$286.940+8.560 (3.075%)

リアルタイム価格

Healthcare
Medical Instruments & Supplies
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$278.380

高値

$287.875

安値

$277.195

出来高

0.41M

企業ファンダメンタルズ

時価総額

20.6B

業種

Medical Instruments & Supplies

United States

取引統計

平均出来高

0.64M

取引所

NYQ

通貨

USD

52週レンジ

安値 $187.43現在値 $286.940高値 $348.9

関連ニュース

Analyst Upgrades

TD Cowen Initiates Coverage On West Pharmaceutical Servs with Buy Rating, Announces Price Target of $350

TD Cowen analyst Brendan Smith initiates coverage on West Pharmaceutical Servs with a Buy rating and announces Price Target of $350.

もっと見る
TD Cowen Initiates Coverage On West Pharmaceutical Servs with Buy Rating, Announces Price Target of $350
Analyst Upgrades

Barclays Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $325

Barclays analyst Luke Sergott maintains West Pharmaceutical Servs with a Equal-Weight and raises the price target from $275 to $325.

もっと見る
Barclays Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $325
PR Newswire

West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...

もっと見る
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
Analyst Upgrades

UBS Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $355

UBS analyst John Sourbeer maintains West Pharmaceutical Servs with a Buy and raises the price target from $320 to $355.

もっと見る
UBS Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $355
Analyst Upgrades

Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $350

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs with a Overweight and raises the price target from $325 to $350.

もっと見る
Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $350
PR Newswire

West to Participate in Upcoming Investor Conferences

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...

Analyst Upgrades

Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $390

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs with a Outperform and raises the price target from $350 to $390.

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。